Total Payments
$20,617
2024 Payments
$3,305
Companies
68
Transactions
1,402
Medicare Patients
5,205
Medicare Billing
$483,505
Payment Breakdown by Category
Food & Beverage$20,337 (98.6%)
Education$279.37 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,337 | 1,389 | 98.6% |
| Education | $279.37 | 13 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,255 | 113 | $0 (2024) |
| Novo Nordisk Inc | $1,196 | 97 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,164 | 75 | $0 (2024) |
| ABBVIE INC. | $1,128 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,046 | 72 | $0 (2024) |
| Lilly USA, LLC | $951.99 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $926.23 | 64 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $892.81 | 76 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $851.65 | 52 | $0 (2024) |
| Amgen Inc. | $752.25 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,305 | 188 | AstraZeneca Pharmaceuticals LP ($618.94) |
| 2023 | $3,682 | 224 | AbbVie Inc. ($399.29) |
| 2022 | $2,866 | 189 | AstraZeneca Pharmaceuticals LP ($236.56) |
| 2021 | $2,637 | 191 | Janssen Pharmaceuticals, Inc ($206.61) |
| 2020 | $1,623 | 114 | AstraZeneca Pharmaceuticals LP ($184.59) |
| 2019 | $1,750 | 124 | AstraZeneca Pharmaceuticals LP ($274.77) |
| 2018 | $2,574 | 203 | AstraZeneca Pharmaceuticals LP ($314.51) |
| 2017 | $2,180 | 169 | AstraZeneca Pharmaceuticals LP ($265.45) |
All Payment Transactions
1,402 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,453 | 1,960 | $403,899 | $131,397 |
| 2022 | 15 | 1,193 | 1,782 | $324,331 | $116,245 |
| 2021 | 15 | 1,158 | 1,854 | $256,021 | $119,362 |
| 2020 | 21 | 1,401 | 2,113 | $240,019 | $116,501 |
Total Patients
5,205
Total Services
7,709
Medicare Billing
$483,505
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 324 | 324 | $97,200 | $39,901 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 462 | $129,400 | $32,049 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 275 | 441 | $83,790 | $21,129 | 25.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 36 | $10,800 | $7,083 | 65.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 99 | $15,867 | $6,013 | 37.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 39 | $16,319 | $5,062 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 95 | $4,750 | $2,798 | 58.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 39 | 40 | $6,480 | $2,474 | 38.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,350 | $2,213 | 50.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 96 | 96 | $4,800 | $2,102 | 43.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $3,500 | $2,069 | 59.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 42 | 45 | $4,275 | $1,662 | 38.9% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 15 | 18 | $3,470 | $1,288 | 37.1% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 12 | 12 | $2,925 | $1,244 | 42.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 28 | $2,688 | $1,068 | 39.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 18 | $2,700 | $1,051 | 38.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 30 | $4,800 | $932.94 | 19.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $1,900 | $662.34 | 34.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 59 | $2,065 | $546.21 | 26.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 52 | $1,820 | $50.17 | 2.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 352 | 694 | $162,085 | $50,551 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 295 | 486 | $78,885 | $25,914 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $26,200 | $12,909 | 49.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 36 | 38 | $11,400 | $7,567 | 66.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $10,182 | $4,292 | 42.2% |
About Dr. Eric Smith, DO
Dr. Eric Smith, DO is a Internal Medicine healthcare provider based in Clarks Summit, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295736742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Smith, DO has received a total of $20,617 in payments from pharmaceutical and medical device companies, with $3,305 received in 2024. These payments were reported across 1,402 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($20,337).
As a Medicare-enrolled provider, Smith has provided services to 5,205 Medicare beneficiaries, totaling 7,709 services with total Medicare billing of $483,505. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Clarks Summit, PA
- Active Since 08/09/2005
- Last Updated 12/18/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295736742
Products in Payments
- FARXIGA (Drug) $1,160
- XARELTO (Drug) $988.43
- XIFAXAN (Drug) $863.07
- Kerendia (Drug) $851.65
- TRELEGY ELLIPTA (Drug) $712.17
- REXULTI (Drug) $706.54
- Ozempic (Drug) $587.22
- JARDIANCE (Drug) $551.63
- BREZTRI (Drug) $529.19
- ELIQUIS (Drug) $528.23
- TRINTELLIX (Drug) $525.38
- ENTRESTO (Drug) $504.29
- VRAYLAR (Drug) $468.74
- NURTEC ODT (Drug) $425.70
- Vascepa (Drug) $412.96
- Victoza (Drug) $315.84
- Linzess (Drug) $311.51
- MOUNJARO (Drug) $308.53
- Livalo (Drug) $302.46
- STIOLTO RESPIMAT (Drug) $302.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clarks Summit
Phillip Boccagno, Md, MD
Internal Medicine — Payments: $22,157
Internal Medicine $22,157
Dr. Michael Gordon, Md, MD
Internal Medicine — Payments: $1,588
Internal Medicine $1,588
Haitham Abughnia, Md, MD
Internal Medicine — Payments: $743.62
Internal Medicine $743.62
Dr. John Lisiak, D.o, D.O
Internal Medicine — Payments: $249.98
Internal Medicine $249.98
Dr. Sheela Prahalad, M.d, M.D
Internal Medicine — Payments: $19.97
Internal Medicine $19.97
Dr. Marsha Modery, Md, MD
Internal Medicine
Internal Medicine